|
11. |
Botanical dietary supplement use in peri- and postmenopausal women |
|
Menopause,
Volume 10,
Issue 1,
2003,
Page 65-72
Gail Mahady,
Julie Parrot,
Cathy Lee,
Gina Yun,
Alice Dan,
Preview
|
PDF (309KB)
|
|
摘要:
ObjectiveTo determine use of botanical dietary supplements (BDS) in women between the ages of 40 and 60 years at the University of Illinois at Chicago (UIC) clinics, including information about commonly used BDS, the reason for use, information resources used, and the overall perception of safety and efficacy of BDS.DesignFive hundred female outpatients at UIC clinics were interviewed by healthcare practitioners using a botanical/drug history questionnaire. Respondents were 46.8% African American, 39.6% Caucasian, 11.7% Hispanic, and 1.5% Asian, with a mean age of 50.34 years.ResultsBDS were used by 79% of respondents (n= 395), of which 36.5% used BDS daily. Of the positive respondents, 51.7% used one or two BDS, whereas 48.4% used three or more. Commonly used botanicals included soy (42%), green tea (34.68%), chamomile (20.76%), gingko (20.51%), ginseng (17.97%), Echinacea (15.44%), and St. John's wort (7.34%). Black cohosh, garlic, red clover, kava, valerian, evening primrose, and ephedra were used by less than 15% of respondents. Efficacy ratings were high for BDS, and 68% claimed to have no side effects. Only 3% of respondents obtained BDS information from healthcare professionals, and 70% of respondents were not informing their physician of BDS use.ConclusionsA high percentage of women at UIC clinics were using multiple BDS. The respondents believed that these products were both safe and effective for the treatment of common ailments. Concomitant BDS use with prescription and over-the-counter medications was commonplace, often without a physician's knowledge. Consumer education about the possible benefits and risks associated with BDS use is urgently needed.
ISSN:1072-3714
出版商:OVID
年代:2003
数据来源: OVID
|
12. |
Waist circumference predicts metabolic cardiovascular risk in postmenopausal Chinese women |
|
Menopause,
Volume 10,
Issue 1,
2003,
Page 73-80
Chii-Min Hwu,
Jong-Ling Fuh,
Chin-Fu Hsiao,
Shuu-Jiun Wang,
Shiang-Ru Lu,
Mei-Chih Wei,
Wei-Yi Kao,
Li-Chuan Hsiao,
Low-Tone Ho,
Preview
|
PDF (322KB)
|
|
摘要:
ObjectiveThe purpose of the study is to compare the differences in metabolic cardiovascular risk factors among postmenopausal Chinese women with or without abdominal obesity.DesignThe study is a cross-sectional, population-based, comparative cohort study. Each participant received anthropometric measurements and a 75-g oral glucose tolerance test after an overnight fast. The homeostasis model assessment for insulin resistance and the insulin sensitivity index, ISI0,120, were used as measures of insulin resistance. A “metabolic cardiovascular risk score” was calculated from fasting insulin, glucose, lipids, and blood pressure. General linear models (GLM) were fit to examine the relation of waist circumference (WC) to insulin resistance and metabolic risk scores.ResultsAccording to the International Obesity Task Force obesity criteria for Asians, 57 women had abdominal obesity (WC ≥ 80 cm), and 58 had WCs less than 80 cm. The two groups were comparable in demographic variables and body mass index (BMI). The women with larger WCs were more insulin-resistant than their counterparts. The metabolic risk scores were significantly higher in women with abdominal obesity than in those without it. The results from the GLM showed that WC was an independent predictor of insulin resistance and metabolic risk scores after controlling for demographic variables (0.06- and 0.29-unit increases in homeostasis model assessment for insulin resistance and metabolic risk scores per 1 cm change in WC). Moreover, BMI neither correlated with metabolic risk scores nor affected the WC effects on insulin resistance and metabolic risk scores in the GLM.ConclusionsPostmenopausal Chinese women with adbominal obesity may carry higher metabolic cardiovascular risk than those without it. It is WC, not BMI, that predicts metabolic cardiovascular risk factors in these women.
ISSN:1072-3714
出版商:OVID
年代:2003
数据来源: OVID
|
13. |
Hot flushes in a male population aged 55, 65, and 75 years, living in the community of Linköping, Sweden |
|
Menopause,
Volume 10,
Issue 1,
2003,
Page 81-87
Anna-Clara Spetz,
Mats Fredriksson,
Mats Hammar,
Preview
|
PDF (277KB)
|
|
摘要:
ObjectiveHot flushes are as common in castrated men as in menopausal women. We investigated whether hot flushes exist in a normal aging male population and to what extent.DesignA questionnaire was sent to all men living in Linköping, Sweden, who were 55, 65, and 75 years old (N= 1,885). The questionnaire asked for demographic data, medical history, mood status, medication, castrational therapy, and smoking, exercise, and alcohol habits, among other items. We asked specifically for current hot flushes unrelated to exercise or a warm environment.ResultsOf the questionnaires received, 1,381 were eligible for evaluation; 33 were analyzed separately because these men had been castrated. Hot flushes of any frequency were reported by 33.1% of noncastrated men, 4.3% reported flushes at least a few times per week, and 1.3% reported daily flushes. Half of the men reporting flushes were also bothered by them, ie, almost every sixth man in total. We found a relation between occurrence of hot flushes and other symptoms thought to be related to low testosterone concentration, such as decreased muscle strength or endurance, decreased enjoyment of life, sadness or grumpiness, and lack of energy (P< 0.05).ConclusionsHot flushes occur in one third of a population of noncastrated older men, approximately half of whom consider flushes as bothersome. Neither the mechanisms nor whether the symptoms would respond to testosterone supplementation is known. Androgen substitution to treat symptoms possibly related to a male climacteric is still controversial. Studies are needed to evaluate the needs for and the effects of androgen treatment on vasomotor symptoms.
ISSN:1072-3714
出版商:OVID
年代:2003
数据来源: OVID
|
14. |
Intranasal hormone replacement therapy |
|
Menopause,
Volume 10,
Issue 1,
2003,
Page 88-98
Saranya Wattanakumtornkul,
Anil Pinto,
Daniel Williams,
Preview
|
PDF (431KB)
|
|
摘要:
Although the optimal route of delivery for hormone replacement therapy has not yet been determined, desirable qualities would include good efficacy, easy administration, minimal side effects, and optimal therapeutic profile. This would potentially serve to improve patient compliance and satisfaction. The intranasal route has been evaluated for the administration of menopausal hormones and seems to fulfill these requirements. The intranasal route would also seem to be a viable alternative for drugs that are poorly absorbed after ingestion by avoiding hepatic first-pass elimination. The intranasal route is, therefore, innovative for the delivery of natural sex steroids in postmenopausal women receiving hormone replacement therapy. Early studies demonstrate that it is safe, effective, and acceptable to postmenopausal women. In addition, the nasal administration of a combination of estradiol and progesterone would seem to be an attractive way to deliver hormones to nonhysterectomized postmenopausal women. Providing alternative routes of administration may also enhance compliance.
ISSN:1072-3714
出版商:OVID
年代:2003
数据来源: OVID
|
15. |
Estrogen-related pancreatitis in the setting of normal plasma lipids: case report |
|
Menopause,
Volume 10,
Issue 1,
2003,
Page 99-101
William Blake,
Meron Pitcher,
Preview
|
PDF (130KB)
|
|
摘要:
A case of recurrent acute pancreatitis occurring in conjunction with intermittently used estrogen therapy over 7 years is presented. Estrogens have been associated with pancreatitis in the past, and a causal link involving elevated plasma triglyceride levels has usually been assumed. The current case is distinct in that the plasma lipids of this patient have always been normal, suggesting that a different mechanism must be responsible for the onset of pancreatitis.
ISSN:1072-3714
出版商:OVID
年代:2003
数据来源: OVID
|
16. |
Letters to the Editor |
|
Menopause,
Volume 10,
Issue 1,
2003,
Page 102-103
Christian Egarter,
Preview
|
|
ISSN:1072-3714
出版商:OVID
年代:2003
数据来源: OVID
|
17. |
Letters to the Editor |
|
Menopause,
Volume 10,
Issue 1,
2003,
Page 103-105
Herbert Kuhl,
Inka Wiegratz,
Preview
|
|
ISSN:1072-3714
出版商:OVID
年代:2003
数据来源: OVID
|
18. |
Letters to the Editor |
|
Menopause,
Volume 10,
Issue 1,
2003,
Page 105-106
Susan Davis,
Evan Simpson,
Preview
|
|
ISSN:1072-3714
出版商:OVID
年代:2003
数据来源: OVID
|
19. |
Letters to the Editor |
|
Menopause,
Volume 10,
Issue 1,
2003,
Page 106-107
Herbert Kuhl,
Inka Wiegratz,
Preview
|
|
ISSN:1072-3714
出版商:OVID
年代:2003
数据来源: OVID
|
|